Thomas Dorn Selected Research

Thomas Dorn Research Topics

7	Epilepsy (Aura) 01/2019 - 10/2008
5	Seizures (Absence Seizure) 12/2019 - 08/2011
4	Epileptic Syndromes 12/2019 - 10/2013
4	Temporal Lobe Epilepsy 09/2015 - 08/2011
3	Febrile Seizures (Febrile Seizure) 12/2019 - 10/2013
2	Brain Diseases (Brain Disorder) 01/2016 - 04/2015
2	Type 2B2 Charcot-Marie-Tooth disease 10/2009 - 10/2009
1	Partial Epilepsies (Epilepsy, Partial) 12/2019
1	Generalized Epilepsy 12/2019
1	Neurologic Manifestations (Neurological Manifestations) 12/2019
1	Focal Cortical Dysplasia 01/2019
1	Neurodevelopmental Disorders 05/2017
1	Idiopathic Generalized Epilepsy 09/2015
1	Leigh Disease (Leigh's Disease) 03/2015
1	Nonsyndromic Deafness 03/2015
1	Hearing Loss (Hearing Impairment) 03/2015
1	Fever (Fevers) 12/2014
1	Hippocampal Sclerosis 10/2013
1	Burns 04/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2009

4	Proteins (Proteins, Gene)FDA Link 12/2019 - 10/2009
4	Pharmaceutical PreparationsIBA 12/2019 - 08/2011
2	Syntaxin 1IBA 12/2019 - 12/2014
2	Sodium Channels (Sodium Channel)IBA 05/2017 - 10/2013
2	Biological ProductsIBA 10/2013 - 04/2012
2	RNA (Ribonucleic Acid)IBA 10/2009 - 10/2009
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2017
1	SodiumIBA 05/2017
1	Sodium Channel BlockersIBA 05/2017
1	Voltage-Gated Sodium ChannelsIBA 05/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	Immunoglobulin E (IgE)IBA 09/2015
1	GalaninIBA 06/2015
1	NeuropeptidesIBA 06/2015
1	Kv1.2 Potassium ChannelIBA 04/2015
1	Asn Transfer RNAIBA 03/2015
1	asparaginyl-tRNA synthetaseIBA 03/2015
1	Mutant Proteins (Protein, Mutant)IBA 03/2015
1	Complement System Proteins (Complement)IBA 03/2015
1	SolutionsIBA 04/2012
1	Lamotrigine (Lamictal)FDA LinkGeneric 10/2008

1	Therapeutics 05/2017
1	Contraindications 08/2011